The Valley Desk

NCT02143726 · Interventional trial

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer

Overall registry status Active not recruiting

Phase 2

Conditions Refractory Hurthle Cell Thyroid Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov